Trial reportJournal of neuro-oncology2026
Construction and application of an ERAS-based nursing pathway for postoperative pain management in brain tumor patients.
Trial report in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo construct an enhanced recovery after surgery (ERAS)-based nursing pathway for postoperative pain management in brain tumor patients and to evaluate its clinical efficacy.
methodsThis study was conducted in two phases. In the first phase (June 2022-December 2024), clinical data from 532 patients receiving brain tumor surgery were collected to analyze risk factors for moderate-to-severe postoperative pain (NRS score ≥ 4). A nursing pathway was developed by integrating the results of multivariate analysis with ERAS principles. In the second phase (January 2025-June 2025), 100 brain tumor patients were randomized to ERAS or control group (n = 50/group). Postoperative outcomes, including pain scores, daily analgesic consumption, functional recovery, hospital stay, complications, and nursing satisfaction, were compared.
resultsMultivariate analysis identified hypertension, preoperative headache, anxiety, depression, poor sleep quality, operative duration ≥ 6 h, perioperative corticosteroid use, delayed first ambulation, and postoperative nausea and vomiting (PONV) within 24 h as independent risk factors for moderate-to-severe pain. Compared to controls, the ERAS group demonstrated lower NRS scores on postoperative day 1/3/5 (P < 0.01), reduced daily analgesic consumption and fewer rescue analgesia requests. Time to first ambulation occurred significantly earlier and hospital stay was shortened in the ERAS group. No statistical difference was observed in complication rates; however, nursing satisfaction was significantly higher in the ERAS group.
conclusionERAS-based nursing pathway effectively alleviates postoperative pain, reduces analgesic requirements, accelerates recovery, and enhances satisfaction in brain tumor patients without increasing complication risks, demonstrating substantial clinical utility and potential for broader implementation.
Indexed as
Identifiers
41618043What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.